Pharma Companies Threaten Investment Pullback Amid Germany Drug Pricing Debate
London: Global pharmaceutical companies, facing pushback from European capitals on drug pricing, are turning to a playbook that brought them recent success in Britain: threats of pulling investment and expansion plans to pressure policymakers. The latest …